- Home
- BBNX vs OPK Comparison
BBNX vs OPK Comparison
Compare BBNX & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBNX | OPK |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 997.9M | 1.0B |
| IPO Year | 2025 | 2011 |
Fundamental Metrics
Financial Performance| Metric | BBNX | OPK |
|---|---|---|
| Price | $16.91 | $1.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 6 |
| Target Price | ★ $24.24 | $4.15 |
| AVG Volume (30 Days) | 912.1K | ★ 3.5M |
| Earning Date | 10-27-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 78.95 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $100,251,000.00 | ★ $606,879,000.00 |
| Revenue This Year | $25.74 | N/A |
| Revenue Next Year | $44.51 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 53.94 | N/A |
| 52 Week Low | $8.80 | $0.98 |
| 52 Week High | $32.71 | $1.77 |
Technical Indicators
Market Signals| Indicator | BBNX | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 40.96 | 56.54 |
| Support Level | $15.76 | $1.46 |
| Resistance Level | $18.20 | $1.74 |
| Average True Range (ATR) | 0.87 | 0.09 |
| MACD | -0.29 | 0.01 |
| Stochastic Oscillator | 24.84 | 62.77 |
Price Performance
Historical ComparisonAbout BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.